These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12916518)

  • 1. Drugs to promote sinus rhythm reversion and maintenance in atrial fibrillation--why amiodarone is better.
    Nattel S
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):5-6. PubMed ID: 12916518
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study.
    Villani GQ; Piepoli MF; Terracciano C; Capucci A
    Am Heart J; 2000 Sep; 140(3):e12. PubMed ID: 10966543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amiodarone and diltiazem on persistent atrial fibrillation conversion and recurrence rates: a randomized controlled study.
    Manios EG; Mavrakis HE; Kanoupakis EM; Kallergis EM; Dermitzaki DN; Kambouraki DC; Vardas PE
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):31-9. PubMed ID: 12843685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.
    Galperín J; Elizari MV; Chiale PA; Molina RT; Ledesma R; Scapín AO; Blanco MV; Bonato R; Lago M;
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):179-86. PubMed ID: 14506542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation: maintaining stability of sinus rhythm or ventricular rate control? The need for prospective data: the PIAF trial.
    Hohnloser SH; Kuck KH
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 1):1989-92. PubMed ID: 9272538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation control and cardioversion.
    Harrison RA; Liratsopulos G
    Lancet; 2001 Apr; 357(9262):1127-8. PubMed ID: 11303604
    [No Abstract]   [Full Text] [Related]  

  • 7. Diltiazem versus amiodarone to prevent atrial fibrillation in coronary surgery.
    Mikroulis D; Didilis V; Konstantinou F; Tsakiridis K; Vretzakis G; Bougioukas G
    Asian Cardiovasc Thorac Ann; 2005 Mar; 13(1):47-52. PubMed ID: 15793051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF).
    Hohnloser SH; Kuck KH
    Eur Heart J; 2001 May; 22(10):801-2. PubMed ID: 11350085
    [No Abstract]   [Full Text] [Related]  

  • 9. Pretreatment of patients with atrial fibrillation who undergo electrical cardioversion.
    Stabile G; Turco P; De Simone A
    Circulation; 2003 Mar; 107(11):e75; author reply e75. PubMed ID: 12654622
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative effects of amiodarone, diltiazem, and atenolol on results of electrical cardioversion in patients with chronic atrial fibrillation].
    Kanorskiĭ SG; Zingilevskiĭ KB
    Kardiologiia; 2002; 42(8):44-5. PubMed ID: 12494094
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate control at least as effective as rhythm control for AF patients.
    Geriatrics; 2002 May; 57(5):63. PubMed ID: 12040594
    [No Abstract]   [Full Text] [Related]  

  • 13. Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.
    Hohnloser SH; Kuck KH; Lilienthal J
    Lancet; 2000 Nov; 356(9244):1789-94. PubMed ID: 11117910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
    Aronow WS
    Cardiol Rev; 2008; 16(4):181-8. PubMed ID: 18562808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical questions #5: Maintenance of normal sinus rhythm after cardioversion: is amiodarone better than placebo?
    Fuh A; Feldstein DA
    WMJ; 2005 Sep; 104(7):17-8. PubMed ID: 16294592
    [No Abstract]   [Full Text] [Related]  

  • 16. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN; Tang XC; Reda D; Singh BN
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias.
    Delle Karth G; Geppert A; Neunteufl T; Priglinger U; Haumer M; Gschwandtner M; Siostrzonek P; Heinz G
    Crit Care Med; 2001 Jun; 29(6):1149-53. PubMed ID: 11395591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone before electrical cardioversion of atrial fibrillation.
    Veloso HH
    Am J Cardiol; 2001 Aug; 88(4):466. PubMed ID: 11558468
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Findings suggest revised atrial fibrillation approach.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(1):7-9. PubMed ID: 12762304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.